现在位置 >首页 > dubin98发表的所有文章
dubin98 ⁄ 发表于3年前 研究点评, 进展交流 [Lancet Respir Med发表述评]:是否需要3年时间才知道瑞德西韦能够挽救生命?已关闭评论
COMMENT|ONLINE FIRST Remdesivir saves lives. Were 3 years needed to learn that? Andre C Kalil Lancet Respir Med Published: F......
dubin98 ⁄ 发表于3年前 研究点评, 进展交流 [ICU Management & Practice]: 疲劳对麻醉科医生的影响已关闭评论
Impact of Fatigue on Anaesthesia Providers Fatigue is being recognised as a workplace hazard of increasing concern. It is a si......
dubin98 ⁄ 发表于3年前 时讯速递, 进展交流 [Lancet Rheumatol发表论文]:免疫球蛋白、糖皮质激素或联合治疗儿童多系统炎症综合征已关闭评论
ARTICLES|ONLINE FIRST Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a ......
dubin98 ⁄ 发表于3年前 研究点评, 进展交流 [Lancet Infect Dis发表述评]:真实世界中奈玛特韦-利托那韦对新冠病毒BA.4和BA.5奥密克戎变异株的有效性已关闭评论
COMMENT|ONLINE FIRST Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants Carlo......
dubin98 ⁄ 发表于3年前 时讯速递, 进展交流 [Lancet Respir Med发表论文]:新冠病毒疫苗对成年人感染、住院及死亡的长期效果已关闭评论
ARTICLES|ONLINE FIRST Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: ......
dubin98 ⁄ 发表于3年前 研究点评, 进展交流 [ICU Management & Practice]: 脓毒症质量指标从过程向结局的转变已关闭评论
Shifting Sepsis Quality Measures From Processes to Outcomes Sepsis is a significant health issue that leads to high rates of d......
dubin98 ⁄ 发表于3年前 时讯速递, 进展交流 [Lancet Respir Med发表论文]:瑞德西韦治疗新冠病毒感染住院患者的效果已关闭评论
ARTICLES|ONLINE FIRST Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient dat......
dubin98 ⁄ 发表于3年前 时讯速递, 进展交流 [Lancet Microbe发表论文]:新冠病毒疫苗疗效及其与三种主要抗体的量效关系已关闭评论
ARTICLES|ONLINE FIRST Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic......
dubin98 ⁄ 发表于3年前 研究点评, 进展交流 [Lancet Infect Dis发表述评]:服用及未服用抗病毒药物时新冠病毒的反跳已关闭评论
COMMENT|ONLINE FIRST SARS-CoV-2 rebound with and without antivirals Nicola Petrosillo Lancet Infect Dis Published: February ......
dubin98 ⁄ 发表于3年前 时讯速递, 进展交流 [Lancet Infect Dis发表论文]:新冠病毒感染患者的抗生素耐药已关闭评论
ARTICLES| VOLUME 4, ISSUE 3, E179-E191, MARCH 2023 Antimicrobial resistance in patients with COVID-19: a systematic......
×
腾讯微博